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Abstract
Background: In medical research, one common competing risks situation is the study of different types of events,
such as disease recurrence and death. We focused on that situation but considered death under two aspects:
“expected death” and “excess death”, the latter could be directly or indirectly associated with the disease.
Methods: The excess hazard method allows estimating an excess mortality hazard using the population (expected)
mortality hazard. We propose models combining the competing risks approach and the excess hazard method.
These models are based on a joint modelling of each event-specific hazard, including the event-free excess death
hazard. The proposed models are parsimonious, allow time-dependent hazard ratios, and facilitate comparisons
between event-specific hazards and between covariate effects on different events. In a simulation study, we
assessed the performance of the estimators and showed their good properties with different drop-out censoring
rates and different sample sizes.
Results: We analyzed a population-based dataset on French colon cancer patients who have undergone curative
surgery. Considering three competing events (local recurrence, distant metastasis, and death), we showed that the
recurrence-free excess mortality hazard reached zero six months after treatment. Covariates sex, age, and cancer
stage had the same effects on local recurrence and distant metastasis but a different effect on excess mortality.
Conclusions: The proposed models consider the excess mortality within the framework of competing risks.
Moreover, the joint estimation of the parameters allow (i) direct comparisons between covariate effects, and (ii)
fitting models with common parameters to obtain more parsimonious models and more efficient parameter
estimators.
Keywords: Excess hazard, Competing risks, Time-dependent hazard ratio, Regression splines, Cancer, Population-
based study
Background
Analysis of failure time data is one of the major fields of
statistics, death (whatever its cause) being the event of
interest. However, in some other situations, several types
of events are considered and the occurrence of one type
prevents the occurrence of the others, creating a context
of competing risks. Initially, in that context, a subject
would fail because of only one of several different event
types (for example, different causes of death). However, a
patient may undergo successively several event types and
be considered in a situation of competing risks. For
example, in a study of the efficacy of a treatment on a
chronic disease, it may be interesting to analyse time to
recurrence. However, a patient may present recurrence
and then die or die before recurrence. This example may
be analysed within the competing risks framework limit-
ing the analysis to the first occurring event, this event
being sufficient to indicate treatment failure [1,2]. When
one is also interested in what happens after the first non-
fatal event (e.g., recurrence), subsequent events may be
seen as transitions from one state to another; this defines
the framework of multi-state models [3,4]. However, in
this work, we were interested in the estimation of the
first-event-specific hazard functions and the covariate
effects. Therefore, as in the “conventional” competing
risks setting, we limited our analysis to the first occurring
event whatever its type [1,4].
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Our work was motivated by a dataset from a French
population-based study on colon cancer patients who
have undergone curative surgery. Although surgery
remains the primary treatment, the incidence of recur-
rence after surgery increases during the first five years
reaching 12.8% for local recurrence and 25.6% for dis-
tant metastasis [5]. The identification of the clinical vari-
ables associated with this treatment failure is important
to determine the optimal strategy for patient follow-up,
which remains controversial [6]. Moreover, patients who
have undergone curative surgery and who have not
experienced local recurrence or distant metastasis are
still exposed to death. One might then wonder whether
these patients are “cured” (i.e., their mortality has
become similar to that of the general population) or still
suffer excess mortality. Then, an approach based on the
excess hazard model should help distinguishing
expected deaths (in line with the general population
mortality) from excess deaths which may be directly or
indirectly related to colon-cancer [7-9].
Our objective was therefore to estimate both the
excess mortality hazard and the recurrence-event
hazard. Moreover, we were interested in (i) checking
whether a given covariate may have the same impact on
the different events, in particular on two related types of
events such as “local recurrence” and “distant metasta-
sis”, and (ii) testing whether the excess mortality and
recurrence-hazard are proportional or not; i.e., whether
their ratio is constant over time or time-dependent in
order to model it in a flexible way when appropriate. To
achieve these objectives, among the many developments
of the competing risk theory over the last 30 years
[10-15], we used a joint modelling of the hazards asso-
ciated with each type of event [4,16-19]. Indeed, the
joint modelling offers, in a straightforward single analy-
sis, the possibility to compare event-specific baseline
hazards and to compare covariate effects associated with
different types of events. We extended the flexible
approach recently proposed to model competing risks in
survival analysis [20] to the context of excess mortality
and first recurrent-event hazard. Another advantage is
that the model can be fitted with some of the para-
meters common to all event types to obtain a more par-
simonious model and more efficient parameter
estimators [4,18].
The paper is organized as follows. In the next section,
we present our motivating example of competing risks
in a prognostic study of colon cancer. Section Methods
introduces the excess hazard model in case of a single
event, the background of the competing risk methodol-
ogy, then presents our competing risk models proposed
to estimate jointly the excess mortality and the recur-
rent-specific hazards. In section Results, we present the
analysis strategy of the motivating example and show
the results. We conclude this article with a discussion of
the findings and an outline of further developments.
Motivating example
FRANCIM network is an association that joins all vali-
dated French Cancer Registries. The original dataset
that stems from a “High-Resolution study” of nine
French cancer registries consists of 1016 incident cases
of colon cancer (caecum to rectosigmoid junction; C18
and C19 according to the International Classification of
Diseases for Oncology, 3rd revision) diagnosed in 1995
and treated with curative intent (surgery or endoscopic
resection). Observations with unknown cancer stage at
diagnosis were excluded from the analysis (n = 45).
Moreover, 35 patients with synchronous distant metas-
tasis at diagnosis (i.e., Stage IV) were also excluded
because the occurrence of metastasis was one of the
events under study. Thus, the analysis concerned 936
incident cases of colon cancer.
Three events were of interest: local recurrence, distant
metastasis, and death. The delay from diagnosis to the
first observed event was calculated in each case and
patients’ follow-up was restricted to the first seven years
after diagnosis, time at which patients still at risk were
censored. The mean age at diagnosis was 71 years
(range: 21 to 100). The patients were 455 women (49%)
and 481 men (51%). The cancer stages at diagnosis were
256 stage I (27%), 289 stage II (42%), and 291 stage III
(31%). During the study period, there were 60 local
recurrences, 143 distant metastases, and 206 deaths.
The study population presented a persistent mortality
after curative intent treatment. Within such a context,
an analysis of excess death with no recurrence (local or
distant) should provide new insights into the course of
the disease and the impact of the treatment.
Methods
The excess mortality hazard model
In the classical additive form, the overall mortality hazard
function, lO, is split into an excess hazard function, l+,
and a population (or expected) hazard function lP
λO(t, a, x, z) = λ+(t, x) + λP(a + t, z) (1)
where t is time since diagnosis, a the age at diagnosis,
x a vector of covariates, and z a vector of population
characteristics [8,9].
The population hazard function lP(a + t, z) in (1) is
assumed to be known and is usually quantified on the
basis of a vector z of population characteristics (gener-
ally age, sex, and possibly place of residence, etc.) and
may be obtained from national statistics institutes. In
previous works, the excess hazard function was mod-
elled by proportional hazard (PH) models l+(t, x) = l0
(t)exp(bx) with l0(t) constant within pre-specified
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intervals of follow-up [8,9]. Modelling the baseline
hazard function and relaxing the PH assumption were
also proposed using either regression splines or frac-
tional polynomials [21-23].
Background of the competing risks
Competing risk data in a sample of N patients give rise
to a right censored sample (ti,δi,ji,xi), i = 1,...,N where ti
is the time to the first event, δi the status (or failure)
indicator equal to 1 in subjects i that present any event
and 0 otherwise, ji the type of event (for example, in the
case of three competing events, ji = 1,2,3 and ji = 0 if
the subject is censored at ti), and xi a vector of
covariates.
Assuming a random censoring mechanism, the full
likelihood function [10] is:
N∏
i=1
S(ti, xi)
J∏
j=1
[
λj(ti, xi)
]I(ji=j) (2)
where lj(t,x) is the event j-specific hazard,
S(t, x) = exp(−
t∫
0
J∑
j=1
λj(u, x)du) the overall (all-events)
survival in the case of J distinct types of events, which
quantifies the probability of surviving until time t with-
out experiencing any of the J distinct events, and I(ji = j)
is the indicator function equal to 1 for a event of type j
observed at time ti.
When death is among the J event types, the event-spe-
cific hazard for death represents the mortality hazard
due to all causes; i.e., the observed deaths combine
“expected deaths” and “excess deaths”. The excess
hazard model offers an attractive approach to evaluate
the event-specific hazard associated with “excess death”
and to assess the effect of the covariates on the excess
mortality hazard.
New competing risk models in excess mortality analysis
The proposed models
The new model combining the excess mortality hazard
model and the competing risk model may be written:
λj(t, a, x, z) = λ1(t) exp
[
bj +
K∑
k=1
αkxk +
K∑
k=1
βjkxk
]
+I(j = death)λP(a + t, z)
(3)
where, in case of K covariates, b1 = 0 and b1k = 0, k =
1,...,K for uniqueness.
To simplify the interpretation of model (3), we consid-
ered J = 3 different events with event “death” denoted by
j = 3 as an example. That model assumes a common pat-
tern for the baseline hazards through l1(t) which repre-
sents the baseline hazard for individuals experiencing the
‘reference’ event 1 and with vector of covariates x equal
to 0. In model (3), the log of the baseline hazard of event
1, log(l1(t)), is modelled by a cubic regression spline with
one knot located at 1 year. The interior knot location at 1
year is suggested because, in many cancers, a large pro-
portion of events are observed during the first year after
diagnosis. However, the user may either choose another
knot location, based on substantive knowledge about the
disease or, in the absence of such knowledge, locate the
interior knot at the median of the sample distribution of
uncensored event times, which ensures equal data sup-
port for both functional segments. A cubic regression
spline is a smooth piecewise polynomial function of
order 4 in which the constraint is that the function and
its first two derivatives should be continuous at the knots
where the adjacent pieces of the polynomial join [24,25].
Since the baseline hazard for event 1 is l1(t), the baseline
hazard for the event j ≠ 1 is simply lj(t,x = 0) = l1(t)exp
(bj). For event death, the baseline hazard is l1(t)exp(b3)
which represents the baseline of the “event-free excess
death hazard”. The model (3) assumes PH effects of cov-
ariates x on the event-specific hazards. For one unit
increase of a given covariate xk, the effect is split into a
common (or shared) effect through the regression para-
meter ak, and a differential event-specific effect through
the regression parameter bjk. In the same way, the HRs
will be estimated by exp(ak) and exp(ak + bjk) for events
1 and j, respectively. So, the comparison between covari-
ate effects on event 1 and event j can be directly tested
by H0: bjk = 0 using the classical Wald test or the likeli-
hood ratio (LR) test. Moreover, when the effect of a cov-
ariate on one event type is not significantly different from
the common effect, a simpler and more parsimonious
variant of model (3) can be fitted, including only the
common effect ak of this covariate.
However, the assumption of a common pattern for
event-specific hazards through l1(t) may seems dubious
[17,20]. To overcome this limit of our new model (3),
we propose to introduce a time-dependent log HR, bj(t),
between event-specific hazards.
The new flexible model may be written:
λj(t, a, x, z) = λ1(t) exp
[
bj(t) +
K∑
k=1
αkxk +
K∑
k=1
βjkxk
]
+I(j = death)λP(a + t, z)
(4)
where, in case of K covariates, b1(t) = 0 and b1k = 0, k
= 1,...,K for uniqueness.
In the flexible model (4), the log of the baseline
hazard of event 1, log(l1(t)), and the time-dependent log
HRs between event-specific hazard, bj(t), are modelled
by cubic regression splines, each spline having one knot
located at 1 year. (Note that while all spline functions in
(3) and (4) use the same cubic B-spline basis, the
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resulting functional estimates may differ substantially in
their values and shapes, depending on the estimated
spline coefficients). Then, each time-dependent effect is
modelled by a 5-degree-of-freedom (df) function [26]
and a LR test with 4 df can be used to compare a model
with a constant bj versus a model with bj(t) (i.e., to com-
pare the new model (3) to the new flexible model (4)).
Therefore, in the case of non-significant time-dependent
effects bj(t),j = 2...J, the simpler model (3) may be used.
Moreover, model (4) is an important and flexible alter-
native in modelling because some HRs between baseline
hazards may be time-dependent (e.g., death and local
recurrence) whereas others may be constant over time
(e.g., for events close in nature such as local recurrence
and distant metastasis).
Estimation procedure
In both models (3) and (4), the maximum likelihood
estimates are obtained using the trick of data duplica-
tion. A detailed description of data duplication and cod-
ing can be found in references [4,16,17,27]. This trick
allows fitting both models (3) and (4) using any tool for
one survival outcome existing in statistical software,
such as the Cox model [17]. In the present work, the
maximum likelihood estimates are obtained using an
Iterative Reweighted Least Square procedure developed
for a previous spline-based model [23]. This procedure
is based on split data, which approximates the contribu-
tion of each individual to the full log-likelihood by a
sum of Poisson terms on time intervals that are suffi-
ciently small for the assumption of a constant rate to be
acceptable [23,28]. Doing so, the parameters can be esti-
mated within the framework of the generalized linear
models assuming a Poisson distribution for the observed
number of deaths. However, as pointed by Dickman et
al., the user has to specify a particular link function for
the generalized linear model to take into account the
general population mortality in the estimation procedure
[29].
Performance of the estimators
Simulation studies were conducted to assess the perfor-
mance of the estimators obtained from model (4) in the
case of three competing events (of whom death) and dif-
ferent sample sizes and censoring rates. Data generation,
simulation design, and results are detailed in Additional
file 1.
Briefly, the times to the events were supposed to
depend on three independent prognostic factors. Differ-
ent rates of drop-out censoring (0%, 15%, and 30%) and
different sample sizes (N = 400 and N = 1000) were
considered. The relative biases (RBs) were close to zero
(range: -0.047 to 0.05) whatever the sample size and the
drop-out censoring rate (Additional file 1, Table S1).
Obviously, the RBs increased with the drop-out censor-
ing rate for most parameter estimates and the impact of
the drop-out censoring rate was more important with
N = 400 than with N = 1000. Whatever the sample size
and the drop-out censoring rate, the empirical coverage
rates (ECRs) were close to the nominal level of 95%
(range: 91.8 to 96.6), even when the ECR was slightly
smaller than 95% for the parameter estimates of the
excess mortality hazard function (Additional file 1,
Table S1). Graphically, we have shown that the means
of the estimates of the baseline hazard function of the
three competing events were close to their true baseline
hazard functions (Additional file 1, Figures S1 and S2).
The performances of the estimated time-dependent HRs
relative to event 2 and event 3 (excess death) were
similar.
Results
Analysis strategy
In this analysis, our objectives were: (i) estimate the
baseline hazards, and their ratios, for local recurrence,
distant metastasis, and recurrence-free excess death; (ii)
to estimate the effects of sex, age at diagnosis, and stage
at diagnosis associated with each event-specific hazard;
and (iii) to test whether the effects of covariates are
common to the two related events “local recurrence”
and “distant metastasis” or not.
The strategy consisted of three steps. The first step was
to determine the pattern of the time-dependent HRs
between event-specific hazards. Thus, a Cox PH model
with constant HRs between event-specific hazard func-
tions was used on duplicated data; i.e., with a dummy
variable denoting each type of event introduced as cov-
ariate [4,17]. In this model, the baseline hazard function
was the baseline hazard function for local recurrence.
Using Schoenfeld residuals, the pattern of the time-
dependent HR was obtained graphically [30]. The second
step was to estimate the baseline hazard for local recur-
rence. Considering only local recurrences as events and
censoring the other events, we fitted six models using six
candidate functions of time: constant, linear, quadratic
polynomial, cubic polynomial, regression cubic spline
with one knot at 1 year, and regression cubic spline with
two knots at 1 and 5 year. The final baseline hazard for
local recurrence was selected with the Akaike Informa-
tion Criterion (AIC) [31]. The third step was to jointly
estimate and test the covariate effects with the flexible
model (4), using the time-dependent HR obtained from
the first step and the pattern of the baseline hazard for
local recurrence obtained from the second step. In the
tests described below, we imposed different covariate
effects on the death event than on the two others, and
the test for a given covariate was performed adjusted on
the other covariates. More precisely, to test whether a
covariate x had a different effect on “local recurrence”
than on “distant metastasis”, we compared a version of
Belot et al. BMC Medical Research Methodology 2011, 11:78
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model (4) with a common effect on “local recurrence”
and “distant metastasis” against another version of model
(4) with different effects on “local recurrence” and “dis-
tant metastasis” using a LR test (with 1 df for covariates
sex and age and 2 df for covariate stage). For this analysis,
the population mortality hazard function was obtained
from the French vital statistics published by the Institut
National de la Statistique et des Études Économiques
(INSEE), detailed by sex and age.
Results of the analysis
At the first step of our strategy, it was obvious to use a
constant hazard ratio of the baseline hazards of distant
metastasis event to that of local recurrence event, while
a cubic regression spline with one knot at one year was
used to model the time-dependent HR of the death
event to that of local recurrence event.
At the second step, the AIC approach selected a regres-
sion cubic spline with one knot at 1 year to model the
baseline hazard relative to the local recurrence event. As
shown in Figure 1, the baseline hazards relative to the
local recurrence event and the distant metastasis event
increased to a maximum during the first year after diagno-
sis and then decreased slowly. However, the baseline
hazard relative to the distant metastasis event was higher
than that of the local recurrence event. The baseline
(recurrence-free) excess death hazard was very high just
after diagnosis, probably due to post-surgical complica-
tions; it sharply decreased thereafter until six months then
reached a constant value close to zero. In absence of post-
surgical complications, operated patients were exposed to
the same risk of death as the general population as long as
they did not relapse. Not taking into account the expected
mortality may lead to an erroneous conclusion about the
benefit of surgery. To verify this, we performed an analysis
with a simplified version of the flexible model (4) which
did not incorporate the population hazard lP, in order to
obtain an estimate of the overall recurrence-free mortality
hazard. As shown in Figure 2, the overall mortality hazard
never reached zero; this led to the conclusion of a persis-
tent risk of mortality. With our new flexible model (4), we
observed that curative surgery generates an excess death
due to post-surgical complication only during a few
months after surgery.
Then, in the third step, the tests of common covariate
effects on the events “local recurrence” and “distant
metastasis” were not significant (p = 0.58, p = 0.94, and p
= 0.07 for sex, age, and stage, respectively). The estimated
hazard ratios are shown in Table 1. The effect of sex was
statistically significant on recurrence events (either local
or distant) and protective for women but was not signifi-
cant on the excess death event. The effect of age at diag-
nosis on recurrence events was not significant but it was
significant on excess-death event, old patients having
poorer prognoses than young ones. Cancer stage had the
same strong significant effect on local and distant recur-
rence events. The effect of cancer stage on the excess-
death event was also statistically significant.
Discussion
To our knowledge, model (3) and its flexible refinement
model (4) proposed here are the first to consider com-
peting risks within the framework of the excess hazard
regression model. These new models make it possible
to estimate (i) the hazard function for each type of pre-
specified event, including the recurrence-free excess
death hazard function, (ii) changes over time in their
ratio, and (iii) the effect of covariates on the hazard of
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each event, including the excess death event. Further-
more, the joint estimation of all parameters allows com-
parisons between covariate effects associated with
different types of events in a single analysis. Analysis of
the population-based dataset on French colon cancer
patients using model (4) underlines the importance to
model in a flexible way the ratio of the baseline hazards
of the events and permits new insights into the benefit
of surgery.
A joint modelling of the hazards allows fitting models
with common parameters; this results in more parsimo-
nious models and more efficient parameter estimators
[4,18]. This may be interesting when studying related
events (such as local recurrence and distant metastasis
in cancer patients) to allow some covariates to have the
same effect. The simultaneous estimation on duplicated
data facilitates direct comparisons between event-speci-
fic baseline hazards and also between covariate effects,
using standard statistical tests. Tai et al. compared the
joint modelling of event-specific hazards to other non-
parametric approaches commonly used in competing
risk situations [27]. Their comparisons were based on
graphical representations of the cumulative incidence
function (i.e., the probability for a specific event occur-
ring before a given time t) and they have shown that the
estimates of the cumulative incidence functions obtained
with the joint modelling of hazards were very close to
the non-parametric estimates [27].
In our new model (3), we assumed a common pattern
for all event-specific hazards, which may be dubious in
most cases. Whenever the assumption of a common pat-
tern does not hold, a simple approach could be to analyse
the competing risk data stratified on the type of event.
While this approach assigns different baseline hazard
functions for each type of event, it does not allow com-
parisons between all types of events in a single analysis.
In our new flexible model (4), the introduction of a time-
dependent log HRs bk(t) between event-specific hazards
offers the advantage of relaxing the assumption of a com-
mon pattern and of estimating jointly the baseline
hazards relative to all types of events. As shown in our
colon cancer application, this helps understanding the
natural history of the disease through the way the event-
specific baseline hazard changes over time, including the
recurrence-free excess death hazard. Moreover, a para-
metric framework allows using classical and well-known
inference tools: for example, comparing the model with a
constant bk against the model with bk(t) using the LR test
with the appropriate df allows to test the assumption of
common pattern for baseline hazard functions.
The present work focuses on modelling the event-spe-
cific hazard which is not directly interpretable as the
Table 1 Results of the analysis of 936 French colon cancer patients: Adjusted Hazard Ratios for covariates sex, age
and stage of cancer at diagnosis associated with the events local recurrence, distant metastasis and excess death,
with the 95% confidence interval
Type of event and Covariate Adjusted Hazard Ratio with 95% confidence interval p-value for a 2-tailed Wald test
Local recurrence
Man 1
Woman# 0.71 [ 0.53; 0.94 ] 0.02
Age# 1.00 [ 0.99; 1.01 ] 0.55
Stage I 1
Stage II# 3.50 [ 2.11; 5.80 ] < 0.01
Stage III# 7.36 [ 4.50; 12.05 ] < 0.01
Distant metastasis
Man 1
Woman# 0.71 [ 0.53; 0.94 ] 0.02
Age# 1.00 [ 0.99; 1.01 ] 0.55
Stage I 1
Stage II# 3.50 [ 2.11; 5.80 ] < 0.01
Stage III# 7.36 [ 4.50; 12.05 ] < 0.01
Excess death
Man 1
Woman 0.77 [ 0.42; 1.42 ] 0.74
Age 1.12 [ 1.09; 1.16 ] < 0.01
Stage I 1
Stage II 1.48 [ 0.73; 2.98 ] 0.05
Stage III 2.76 [ 1.39; 5.48 ] 0.02
# The same effect was estimated on local recurrence event and distant metastasis event.
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marginal hazard function. Indeed, interpreting the
event-specific hazard as the marginal function would be
equivalent to assuming independence between compet-
ing events, whereas this assumption cannot be met
[4,10,18,32]. Thus, the HR for the effect of a covariate,
estimated using either the Lunn-McNeil model or the
above-shown models (3) and (4), is interpretable as an
event-specific HR; however, caution must be exercised
when interpreting it in terms of marginal probability.
Under the assumption of independence between differ-
ent types of events, the marginal probability describes
the time to event distribution in a hypothetical situation
where no competing events are assumed to occur
[4,10,33]. An alternative approach for studying compet-
ing risks is to model the subdistribution hazard function
[14], which permits estimating covariate effects that are
directly interpretable in terms of marginal probabilities.
Regression splines have been widely used in classical
survival studies [25,34-36] and in excess hazard models
[21,23]. The main advantage of regression splines is the
possibility to model several kinds of patterns while
being linear in the parameters. Besides, cubic regression
splines offer a good compromise between flexibility and
smoothness [34]. However, the location of the knots
needs a careful consideration. Knots may be fixed ‘a
priori’ whenever the shape of the hazard function is
available. When nothing is known about the hazard
function, the knots may be specified using data-depen-
dent criteria, according to the empirical distribution of
the observed times to events. In our simulations and
application, the knots for cubic regression splines were
chosen ‘a priori’. In colon cancer, a high excess death is
often observed during the first year [21,37]. Cubic
regression splines may also be used to model and to test
non-linear effects of covariates on event-specific hazard
functions in a simple way: since any model with a linear
effect of a given covariate is nested within models with
a non-linear effect of the same covariate modelled using
regression splines, a simple LR test may be used.
Furthermore, when the PH assumption does not hold
for some covariates, the time-dependent effects of these
covariates may be introduced in the flexible model (4)
in the same manner as time-dependent HRs between
event-specific hazard functions. Therefore, model (4)
may be extended to estimate adjusted effects of HRs
between event-specific hazard functions and adjusted
effects of covariates assuming time-dependent effects as
well as constant effects.
The data on colon cancer patients showed an impor-
tant excess death that occurred just after surgery but
decreased thereafter to become null a few months later.
We have shown that if the expected mortality hazard is
not taken into account, the overall mortality hazard will
be more important and never reach zero. Local
recurrence and distant metastasis hazards reached peaks
nearly one year after diagnosis and then decreased
slowly, confirming the importance of keeping patients
under close medical supervision [5,38,39]. The effect of
sex was identical on the three events, men having
poorer prognoses than women and this effect was
advantageously modelled using our model with a (single)
common parameter rather than three.
In this work, we limited the analysis to the first occur-
ring event but other recurrences, as well as death after a
recurrence, may be observed. An interesting future
work, based on the idea of our new model, would be to
study all times to events as multivariate failure-time
data, including an unmeasured “frailty” term to take
into account the correlation between times to events,
such as that between the time to distant metastasis and
the time to excess death [40,41].
Conclusions
The new models proposed in this paper allow consider-
ing competing risks within the framework of excess
hazard regression model. They make it possible to esti-
mate in a flexible way the hazard function for each type
of pre-specified events, including the recurrence-free
excess death hazard function. A joint estimation of all
parameters allows direct comparison between covariate
effects and may provide more parsimonious models and
more efficient parameter estimators.
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